How much Tykerb (lapatinib) did it sell in 2024?
No Tykerb (lapatinib) 2024 sales figure is provided in the available information, so a specific 2024 revenue number can’t be confirmed here.
Which company reports Tykerb sales?
Tykerb is marketed in the U.S. by Novartis. If you’re looking for the 2024 sales number, the most direct place to get it is Novartis’ financial reporting (for example, segment/brand reporting where available) or regulatory/marketplace datasets that track product sales by brand and year.
Where can you find an official 2024 sales number for Tykerb?
Search for one of these sources that breaks out branded product sales by year:
- Novartis annual report / Form 20-F brand or product revenue tables (if shown)
- Novartis quarterly results materials (sometimes include product-level updates)
- Paid datasets that track drug sales (e.g., IQVIA, EvaluatePharma), which often provide yearly brand sales by country
Is Tykerb still sold as a “major” product in 2024?
The question you asked (“Tykerb sales 2024”) usually reflects interest in whether it remained material to the seller’s revenue. Without the underlying 2024 figures, the only reliable statement is that you’ll need a brand-level dataset or the seller’s reporting to quantify it for 2024.
If you tell me your country, I can narrow the search intent
Tykerb sales are typically reported by geography (U.S., EU5, total, etc.). If you share the market you mean (e.g., U.S. only vs worldwide), I can help you target the right kind of source and wording for the number you’re trying to find.
Sources
None provided.